Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Related Citations for PubMed (Select 18938289)

1.
2.

Maternal and fetal C-reactive protein genotype and first trimester CRP concentrations in maternal plasma.

Hackney DN, Dunigan JT, Simhan HN.

J Reprod Immunol. 2008 Oct;79(1):44-9. doi: 10.1016/j.jri.2008.08.005. Epub 2008 Sep 20.

PMID:
18805592
3.

A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia.

Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA.

Am J Hypertens. 2004 Feb;17(2):154-60.

PMID:
14751658
4.

Obstetrical complications associated with abnormal maternal serum markers analytes.

Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, Désilets VA, Johnson JA, Langlois S, Summers A, Wyatt P; Society of Obstetricians and Gynaecologists of Canada Genetics Committee.

J Obstet Gynaecol Can. 2008 Oct;30(10):918-49. Review. English, French.

PMID:
19038077
5.

Placental inflammation and viral infection are implicated in second trimester pregnancy loss.

Srinivas SK, Ma Y, Sammel MD, Chou D, McGrath C, Parry S, Elovitz MA.

Am J Obstet Gynecol. 2006 Sep;195(3):797-802.

PMID:
16949414
6.

Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction.

Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ.

J Reprod Immunol. 2003 Jun;59(1):29-37.

PMID:
12892901
7.

The significance of C-reactive protein levels in women with premature rupture of membranes.

Ismail MA, Zinaman MJ, Lowensohn RI, Moawad AH.

Am J Obstet Gynecol. 1985 Feb 15;151(4):541-4.

PMID:
3976754
8.

Chorioamnionitis: how useful is the determination of C-reactive protein?

Kornman L, Jacobs V, Hodgson RP, Godfrey J, Dunlevy L, Tyler JP, Baird PJ, Hudson CN.

Aust N Z J Obstet Gynaecol. 1988 Feb;28(1):45-8.

PMID:
3214382
9.

The significance of C-reactive protein in the diagnosis of fetal tachycardia and therapy of chorioamnionitis.

Gojnic M, Fazlagic A, Pervulov M, Petkovic S, Mostic T, Jeremic K.

Clin Exp Obstet Gynecol. 2005;32(2):114-6.

PMID:
16108395
10.

Predictive value of C-reactive protein in serum of maternal and cord blood in cases with premature rupture of membranes.

Awara AM, Marei SK, Elghorab NM, Elnewahy MA, Aboulenin AA.

Egypt Med J. 1992 Feb;9(2):31-7.

PMID:
12285340
11.

Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia.

García RG, Celedón J, Sierra-Laguado J, Alarcón MA, Luengas C, Silva F, Arenas-Mantilla M, López-Jaramillo P.

Am J Hypertens. 2007 Jan;20(1):98-103.

PMID:
17198919
12.

C-reactive protein and preterm delivery: clues from placental findings and maternal weight.

Bullen BL, Jones NM, Holzman CB, Tian Y, Senagore PK, Thorsen P, Skogstrand K, Hougaard DM, Sikorskii A.

Reprod Sci. 2013 Jun;20(6):715-22. doi: 10.1177/1933719112466302. Epub 2012 Dec 7.

13.

First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome.

Poon LC, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH.

Prenat Diagn. 2009 Jun;29(6):553-9. doi: 10.1002/pd.2234.

PMID:
19242924
14.

First trimester maternal concentrations of thrombin-inhibitor complexes and the presence of histologic placental lesions at delivery.

Hackney DN, Chiao JP, Macpherson TA, Simhan HN.

J Matern Fetal Neonatal Med. 2009 Oct;22(10):837-42. doi: 10.1080/14767050902822211.

PMID:
19658036
15.

Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester.

Deveci K, Sogut E, Evliyaoglu O, Duras N.

J Obstet Gynaecol Res. 2009 Feb;35(1):94-8. doi: 10.1111/j.1447-0756.2008.00835.x.

PMID:
19215554
16.

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J; CAP Investigators.

Clin Ther. 2008 Dec;30(12):2298-313. doi: 10.1016/j.clinthera.2008.12.023.

PMID:
19167589
17.

Maternal plasma interleukin-6, interleukin-1beta and C-reactive protein as indicators of tocolysis failure and neonatal outcome after preterm delivery.

Skrablin S, Lovric H, Banovic V, Kralik S, Dijakovic A, Kalafatic D.

J Matern Fetal Neonatal Med. 2007 Apr;20(4):335-41.

PMID:
17437242
18.

[Histology of chorioamnionitis: relations to maternal and fetal infection parameters].

Beck T, Bahlmann F, Weikel W.

Z Geburtshilfe Perinatol. 1993 May-Jun;197(3):129-34. German.

PMID:
8367989
19.

First trimester predictors of adverse pregnancy outcomes.

Brameld KJ, Dickinson JE, O'Leary P, Bower C, Goldblatt J, Hewitt B, Murch A, Stock R.

Aust N Z J Obstet Gynaecol. 2008 Dec;48(6):529-35. doi: 10.1111/j.1479-828X.2008.00912.x.

PMID:
19133038
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk